dc.date.accessioned | 2023-01-13T17:56:39Z | |
dc.date.available | 2023-01-13T17:56:39Z | |
dc.date.created | 2022-05-21T15:18:57Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Befring, Anne Kjersti . Transformation of Medical Care through Gene Therapy and Human Rights to Life and Health – Balancing Risks and Benefits. European Journal of Health Law. 2022, 1-22 | |
dc.identifier.uri | http://hdl.handle.net/10852/98748 | |
dc.description.abstract | Abstract
This article is about how somatic gene therapy can be legally regulated and risk assessed as medical treatment when taking the following international human rights conventions into consideration: the right to life in Article 2 of the ECHR and the right to health in Article 12 of ICESCR . The right to life can involve both protection against risky genetic methods and access to necessary health care. In this context, human rights can be a basis for identifying interests that must be considered in a rapid technological development. Focusing mainly on human rights to life and to health, it is argued (1) against a total ban or general moratoriums on gene editing; (2) that regulations should be based on international cooperation and consensus; and that (3) rights to health may involve obligations to provide access to genetic methods. | |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Transformation of Medical Care through Gene Therapy and Human Rights to Life and Health – Balancing Risks and Benefits | |
dc.title.alternative | ENEngelskEnglishTransformation of Medical Care through Gene Therapy and Human Rights to Life and Health – Balancing Risks and Benefits | |
dc.type | Journal article | |
dc.creator.author | Befring, Anne Kjersti | |
cristin.unitcode | 185,12,5,0 | |
cristin.unitname | Institutt for offentlig rett | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 2026184 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European Journal of Health Law&rft.volume=&rft.spage=1&rft.date=2022 | |
dc.identifier.jtitle | European Journal of Health Law | |
dc.identifier.volume | 29 | |
dc.identifier.issue | 3-5 | |
dc.identifier.startpage | 359 | |
dc.identifier.endpage | 380 | |
dc.identifier.doi | https://doi.org/10.1163/15718093-bja10084 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 0929-0273 | |
dc.type.version | PublishedVersion | |